🇺🇸 FDA
Patent

US 8697076

Antibodies selective for pathological tau dimers and prefibrillar pathological tau oligomers and their uses in treatment, diagnosis and monitoring of tauopathies

granted A61PA61P25/28

Quick answer

US patent 8697076 (Antibodies selective for pathological tau dimers and prefibrillar pathological tau oligomers and their uses in treatment, diagnosis and monitoring of tauopathies) held by Northwestern University expires Mon Apr 10 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Northwestern University
Grant date
Tue Apr 15 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 10 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
19
CPC classes
A61P, A61P25/28